Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jan 1;165(1):239-44.
doi: 10.1084/jem.165.1.239.

Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type

H K Prasad, R S Mishra, I Nath

Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type

H K Prasad et al. J Exp Med. .

Abstract

Using a costimulant assay, in vitro Con A responses of patients across the leprosy spectrum were found to be markedly suppressed by phenolic glycolipid-I (PGL-I), a unique antigen of M. leprae. The degree of inducible suppression as well as the number of leprosy patients showing suppression of mitogenic responses was higher with PGL-I as compared with integral M. leprae (p less than 0.05 to less than 0.01). Both untreated lepromatous (60%) as well as tuberculoid leprosy (67%) patients showed significant suppression ranging from 13 to 64% and 12 to 79%, respectively. Thus, PGL-I appears to have a universal suppressive effect on Con A responses and is unlikely to play a central role in determining the leprosy spectrum.

PubMed Disclaimer

References

    1. Lancet. 1981 Dec 19-26;2(8260-61):1372-7 - PubMed
    1. Clin Exp Immunol. 1980 Nov;42(2):203-10 - PubMed
    1. Scand J Immunol. 1982 Jan;15(1):33-48 - PubMed
    1. Clin Exp Immunol. 1982 Jul;49(1):105-14 - PubMed
    1. Clin Exp Immunol. 1983 May;52(2):271-9 - PubMed

Publication types